Differential protein expression of blood platelet components associated with adverse transfusion reactions.

Adverse transfusion reaction Bioinformatic analysis Dysregulated mechanisms Inflammatory disorders Platelet proteome Untargeted label-free method

Journal

Journal of proteomics
ISSN: 1876-7737
Titre abrégé: J Proteomics
Pays: Netherlands
ID NLM: 101475056

Informations de publication

Date de publication:
01 03 2019
Historique:
received: 14 08 2018
revised: 13 12 2018
accepted: 17 12 2018
pubmed: 28 12 2018
medline: 14 5 2020
entrez: 28 12 2018
Statut: ppublish

Résumé

Platelets found within platelet components (PCs) intended for transfusion release inflammatory molecules. Despite the implementation of leukoreduction, some of these PCs are occasionally associated with adverse transfusion reactions (ATRs). The aim of this study was to decipher the platelet proteome in two types of PCs, buffy-coat-derived pooled PCs (PPCs) and single-donor apheresis PCs (SDA-PCs), associated with ATRs. A label-free LC-MS/MS method was used for the proteomic analysis of washed platelet pellets from 3 PPCs and 3 SDA-PCs associated with ATRs, compared to matched controls. Bioinformatics tools allowed us to characterise the differentially expressed (DE) proteins between cases (ATR-PCs) and controls (no.ATR-PCs). From the PPCs and SDA-PCs, 473 and 146 proteins were DE, respectively. The functional interpretation of these proteins revealed enrichment in platelet activation and degranulation as the most important biological process. The most dysregulated pathways were integrin signaling for PPCs and acute phase response signaling for SDA-PCs. Interestingly, inflammatory disorders were found to be enriched in both PC types. Profound proteome changes were found in the platelets of PCs that led to clinical ATRs in patients. This study presents the first exploration of the platelet proteomic signature associated with ATRs and could provide clues to improving transfusion medicine. BIOLOGICAL SIGNIFICANCE: Adverse transfusion reactions (ATRs) can still occur after transfusion of platelet components (PC). This is the first report on the proteomic analysis of PCs associated with ATR. In this study, the contents of PC bags implicated in ATRs were examined. The aims of this study were to characterise molecules that could be central to the inflammation of ATRs and to highlight dysregulated mechanisms to explain the onset of ATRs. Two types of PCs were used: 3 PPCs (each from 5 donors) and 3 SDA-PCs (each from one donor). We have shown that the two types of PCs, from bags undergoing different processing (i.e., sampling, preparation), involve two types of dysregulated - pathophysiological mechanisms associated with the onset of ATRs. The most dysregulated signaling pathways were cytoskeleton and integrin regulation for PPCs, acute phase response signaling and remodelling of adherens junctions for SDA-PCs. Inflammation, platelet activation and degranulation processes were present in both PC types but were more important for PPCs. This proteomics analysis provides a better understanding of the pathophysiological mechanisms involved in ATRs and may lead to novel steps to ensure safe PC transfusion.

Identifiants

pubmed: 30590131
pii: S1874-3919(18)30448-2
doi: 10.1016/j.jprot.2018.12.019
pii:
doi:

Substances chimiques

Proteome 0

Types de publication

Clinical Trial Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

25-36

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Auteurs

Chaker Aloui (C)

GIMAP-EA3064, University of Lyon, Saint-Etienne, France; French Blood Bank (EFS) Auvergne-Rhône-Alpes, Saint-Etienne, France.

Céline Barlier (C)

French Blood Bank (EFS) Auvergne-Rhône-Alpes, Saint-Etienne, France.

Stéphane Claverol (S)

Proteome Platform, CGFB, University of Bordeaux Segalen, Bordeaux, France.

Jocelyne Fagan (J)

French Blood Bank (EFS) Auvergne-Rhône-Alpes, Saint-Etienne, France.

Danielle Awounou (D)

French Blood Bank (EFS) Auvergne-Rhône-Alpes, Saint-Etienne, France.

Emmanuelle Tavernier (E)

Cancerology Institute Lucien Neuwirth, Saint-Priest en Jarez, France.

Denis Guyotat (D)

Cancerology Institute Lucien Neuwirth, Saint-Priest en Jarez, France.

Hind Hamzeh-Cognasse (H)

GIMAP-EA3064, University of Lyon, Saint-Etienne, France.

Fabrice Cognasse (F)

GIMAP-EA3064, University of Lyon, Saint-Etienne, France; French Blood Bank (EFS) Auvergne-Rhône-Alpes, Saint-Etienne, France.

Olivier Garraud (O)

GIMAP-EA3064, University of Lyon, Saint-Etienne, France; National Institute of Blood Transfusion (INTS), Paris, France.

Sandrine Laradi (S)

GIMAP-EA3064, University of Lyon, Saint-Etienne, France; French Blood Bank (EFS) Auvergne-Rhône-Alpes, Saint-Etienne, France. Electronic address: sandrine.laradi@efs.sante.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH